It is clear that inflammasome signaling is vital for rapid responses to infection and injury; however, inflammasome dysregulation and aberrant IL-1 expression also drives the initiation and progression of arthrosclerosis [14], type 2 diabetes and obesity [15], neurodegenerative diseases [16], and cancer [17]. This evidence concerns the gene IL1B and type 2 diabetes mellitus.